Cambridge Investment Research Advisors, Inc. - GEMPHIRE THERAPEUTICS INC ownership

GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 29 filers reported holding GEMPHIRE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of GEMPHIRE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$67,000
-52.5%
176,544
+1.4%
0.00%0.0%
Q2 2019$141,000
-29.1%
174,044
+0.6%
0.00%
-50.0%
Q1 2019$199,000
+43.2%
173,044
+0.6%
0.00%0.0%
Q4 2018$139,000
-60.7%
172,0440.0%0.00%
-33.3%
Q3 2018$354,000
-79.2%
172,044
+2.8%
0.00%
-83.3%
Q2 2018$1,705,000
+56.9%
167,364
+0.2%
0.02%
+50.0%
Q1 2018$1,087,000
-13.9%
166,964
+5.0%
0.01%
-20.0%
Q4 2017$1,263,000
-16.9%
158,964
-0.6%
0.02%
-25.0%
Q3 2017$1,520,000
-22.4%
159,964
+4.5%
0.02%
-31.0%
Q2 2017$1,959,000
+23.9%
153,064
+1.7%
0.03%
+7.4%
Q1 2017$1,581,000150,5640.03%
Other shareholders

There were no reported owners of GEMPHIRE THERAPEUTICS INC in Q1 2018.

NameSharesValueWeighting ↓
View complete list of GEMPHIRE THERAPEUTICS INC shareholders